COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 83 filers reported holding COGENT BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,639,782 | -18.8% | 4,373,311 | -1.4% | 0.00% | 0.0% |
| Q2 2023 | $52,529,593 | +37.7% | 4,436,621 | +25.5% | 0.00% | 0.0% |
| Q1 2023 | $38,156,234 | -4.8% | 3,536,259 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $40,064,556 | -15.7% | 3,465,792 | +8.9% | 0.00% | 0.0% |
| Q3 2022 | $47,502,000 | +103.7% | 3,183,770 | +23.1% | 0.00% | 0.0% |
| Q2 2022 | $23,324,000 | +89.5% | 2,585,804 | +57.4% | 0.00% | – |
| Q1 2022 | $12,306,000 | -13.2% | 1,642,969 | -0.6% | 0.00% | – |
| Q4 2021 | $14,180,000 | +5.6% | 1,652,733 | +3.5% | 0.00% | – |
| Q3 2021 | $13,431,000 | +3.1% | 1,597,116 | -0.6% | 0.00% | – |
| Q2 2021 | $13,031,000 | -30.5% | 1,606,789 | -24.7% | 0.00% | -100.0% |
| Q1 2021 | $18,738,000 | +94.4% | 2,134,243 | +148.6% | 0.00% | – |
| Q4 2020 | $9,641,000 | – | 858,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,038,117 | $46,680,633 | 7.86% |
| COMMODORE CAPITAL LP | 4,319,940 | $49,939 | 7.53% |
| TCG Crossover Management, LLC | 3,631,042 | $41,974,846 | 7.41% |
| Fairmount Funds Management LLC | 2,758,975 | $31,893,751 | 5.06% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5,797,687 | 4.20% |
| Ghost Tree Capital, LLC | 800,000 | $9,248,000 | 3.95% |
| Vivo Capital, LLC | 1,994,941 | $23,062 | 2.66% |
| 5AM Venture Management, LLC | 790,440 | $9,137,486 | 2.46% |
| Frazier Life Sciences Management, L.P. | 2,109,154 | $24,381,820 | 1.52% |
| Logos Global Management LP | 1,100,000 | $12,716,000 | 1.49% |